eylea hd aflibercept injection 8 mg presentations at arvo reinforce continued safety and efficacy and highlight early real world outcomes for patients with serious retinal disease
Monday, April 28, 2025 1 min read
Key Takeaway: eylea hd aflibercept injection 8 mg presentations at arvo reinforce continued safety and efficacy and highlight early real world outcomes for patients with serious retinal disease
Full Press Release Details
eylea hd aflibercept injection 8 mg presentations at arvo reinforce continued safety and efficacy and highlight early real world outcomes for patients with serious retinal disease.